Citation Impact
Citing Papers
Anti-Markovnikov alkene oxidation by metal-oxo–mediated enzyme catalysis
2017 StandoutScienceNobel
Reactive Oxygen Species in Inflammation and Tissue Injury
2013 Standout
Pretreatment with allopurinol in cardiac hypoxic-ischemic reperfusion injury in newborn lambs exerts its beneficial effect through afterload reduction
1999
Oxyl radicals, redox-sensitive signalling cascades and antioxidants
2007 Standout
Molecular identification of a renal urate–anion exchanger that regulates blood urate levels
2002 StandoutNature
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
Dopamine DA2-receptor activation inhibits noradrenaline release in human kidney slices
1993
Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors
1994 StandoutNobel
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
2006 StandoutNobel
Leukotriene B4 stimulates human monocyte-derived dendritic cell chemotaxis
2006
Reduced 125I-meta-iodobenzylguanidine uptake and norepinephrine transporter density in the hearts of mice with MPTP-induced parkinsonism
2006
Selection of boron reagents for Suzuki–Miyaura coupling
2013 Standout
The adolescent brain and age-related behavioral manifestations
2000 Standout
Alpha2C-adrenoceptor overexpression disrupts execution of spatial and non-spatial search patterns
1999 StandoutNobel
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics
1990 StandoutNature
Inhibition of Na+, K+-ATPase in rat renal proximal tubules by dopamine involved DA-1 receptor activation
1993
Dopamine receptors mediate alterations in striato-nigral dynorphin and substance p pathways
1987
Synthesis and Release of Dopamine in Rat Brain: Comparison Between Substantia Nigra Pars Compacta, Pars Reticulata, and Striatum
1989 StandoutNobel
Postsynaptic dopamine (DA) receptor stimulator properties of the putative DA autoreceptor-selective agonist B-HT 920 uncovered by co-treatment with the D-1 agonist SK&F 38393
1987 StandoutNobel
Dopamine D1 Agonist SKF 38393 Increases the State of Phosphorylation of ARPP‐21 in Substantia Nigra
1993 StandoutNobel
Multipoint analysis of reduced 125I-meta-iodobenzylguanidine uptake and norepinephrine turnover in the hearts of mice with 1-methyl-4-phenyl-1,2,3,6-tetrahydroxypyridine-induced parkinsonism
2009
Xanthine oxidoreductase is central to the evolution and function of the innate immune system
2003 StandoutNobel
Autoradiographic localization of dopamine D1 and D2 receptors in rat nucleus accumbens: Resistance to differential rearing conditions
1991 Standout
Drugs acting on brain dopamine receptors: A conceptual re-evaluation five years after the first selective D-1 antagonist
1989
Convergent Pathways for Steroid Hormone- and Neurotransmitter-Induced Rat Sexual Behavior
1994 Science
Cascade Reactions in Total Synthesis
2006 Standout
Antipsychotic Properties of the Partial Dopamine Agonist (−)-3-(3-Hydroxyphenyl)-N-n-Propylpiperidine (Preclamol) in Schizophrenia
1998 StandoutNobel
NADH Oxidase Activity of Human Xanthine Oxidoreductase
1997
Modulatory role of serotonin in neural information processing: Implications for human psychopathology.
1992
Eicosanoids and cancer
2010 Standout
Modulation of calcium currents by a D1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons
1995 StandoutNobel
Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol
2006 Standout
Bladder hyperreflexia induced in marmosets by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
1988
Non-motor features of Parkinson disease
2017 Standout
Review: D1 dopamine receptor—the search for a function: A critical evaluation of the D1/D2 dopamine receptor classification and its functional implications
1987
Opposing roles for dopamine D1 and D2 receptors in the regulation of hypothalamic tuberoinfundibular dopamine neurons
1998
The Conversion of Xanthine Dehydrogenase to Xanthine Oxidase and the Role of the Enzyme in Reperfusion Injury1
1994
Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats
1989
Steroid hormone receptors: Many Actors in search of a plot
1995 Standout
Dopaminergic Supersensitivity in G Protein-Coupled Receptor Kinase 6-Deficient Mice
2003 StandoutNobel
Cytochrome P450: major player in reperfusion injury
2003
Towards the physiological function of uric acid
1993
The Physiology of Endothelial Xanthine Oxidase: From Urate Catabolism to Reperfusion Injury to Inflammatory Signal Transduction
2002
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
1994 Standout
Unusually Broad Substrate Profile of Self‐Sufficient Cytochrome P450 Monooxygenase CYP116B4 from Labrenzia aggregata
2014
IN VITRO REINFORCEMENT OF HIPPOCAMPAL BURSTING: A SEARCH FOR SKINNER'S ATOMS OF BEHAVIOR
1994
Differential Regulation of Dopamine D1A Receptor Responsiveness by Various G Protein-coupled Receptor Kinases
1996 StandoutNobel
Dopamine receptors labelled by [3H] quinpirole
1991
Two dopamine receptors: Biochemistry, physiology and pharmacology
1984
The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes
1988
Alpha-Adrenergic Receptor Subtypes
1980 StandoutNobel
Increased urinary leukotriene excretion in patients with cardiac ischemia. In vivo evidence for 5-lipoxygenase activation.
1992
Selective peripheral dopamine-1 receptor stimulation with fenoldopam in human essential hypertension.
1984
Stereocontrolled total synthesis of (−)-aspidophytine
2003
Directed Evolution: Bringing New Chemistry to Life
2017 StandoutNobel
D 1 Dopamine Receptor Activation Required for Postsynaptic Expression of D 2 Agonist Effects
1987 Science
Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).
1990 Standout
Alpha-adrenergic receptors in liver membranes: Delineation with subtype selective radioligands
1981 StandoutNobel
Interactions of Agonists with Platelet α2-Adrenergic Receptors
1982 StandoutNobel
The Sonogashira Reaction: A Booming Methodology in Synthetic Organic Chemistry
2007 Standout
Mice Deficient in Cellular Glutathione Peroxidase Show Increased Vulnerability to Malonate, 3-Nitropropionic Acid, and 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine
2000 Standout
Evidence that specific dopamine-1 receptor activation is involved in dopamine-induced renin release.
1989
Regulation of noradrenaline release by presynaptic receptor systems
1977
Boron Reagents in Process Chemistry: Excellent Tools for Selective Reductions
2006
Predictive Reward Signal of Dopamine Neurons
1998 Standout
The D-1 Dopamine Receptor and the Search for its Functional Role: From Neurochemistry to Behaviour
1987
Endothelial Dysfunction in Cardiovascular Diseases: The Role of Oxidant Stress
2000 Standout
Mutation of the α2A-Adrenoceptor Impairs Working Memory Performance and Annuls Cognitive Enhancement by Guanfacine
2002 StandoutNobel
Dopamine receptors: applications in clinical cardiology.
1985
Cellular and Molecular Mechanisms of Drug Dependence
1988 StandoutScience
The Neurohumoral Axis in Congestive Heart Failure
1984
Selective peripheral dopamine-1 receptor stimulation. Differential responses to sodium loading and depletion in humans.
1990
Modulation of In Vivo Dopamine Release by D2 but Not D1 Receptor Agonists and Antagonists
1987
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
Anxiolytic-like action of the 3-PPP enantiomers in the Vogel conflict paradigm
1987 StandoutNobel
Dopamine-receptor agonists: Mechanisms underlying autoreceptor selectivity
1985 StandoutNobel
Dopamine in schizophrenia: a review and reconceptualization
1991 Standout
Subclassification of alpha-adrenergic receptors by direct binding studies
1979 StandoutNobel
Enantioselective Total Synthesis of Aspidophytine
2003
A Behavioral Dimension of Constraint
1986
Differential electrophysiological effects of 3-PPP and its enantiomers on dopamine autoreceptors and postsynaptic receptors
1986
D-2 Dopaminergic Agonists and Adenosine 3′5′-Monophosphate Directly Regulate the Synthesis ofα-Melanocyte-Stimulating Hormone-Like Peptides by Cultured Rat Melanotrophs
1986
MODULATION OF ADRENAL CATECHOLAMINE RELEASE BY DA2 DOPAMINE RECEPTORS IN THE ANAESTHETIZED DOG
1988
[3H]WB4101—Caution about its role as an alpha-adrenergic subtype selective radioligand
1980 StandoutNobel
Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity.
1996
Autoradiographic distribution of the D1 agonist [3H]SKF 38393, in the rat brain and spinal cord. Comparison with the distribution of D2 dopamine receptors
1986
Nucleus locus ceruleus: new evidence of anatomical and physiological specificity
1983 Standout
Molecular Mechanisms of Myocardial Remodeling
1999 Standout
Conformational Analysis of D1 Dopamine Receptor Agonists: Pharmacophore Assessment and Receptor Mapping
1996
Cardiovascular Autonomic Dysfunction in Animal Models of Parkinson's Disease
2011
Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities.
1995 Standout
Dopamine Receptors: From Structure to Function
1998 Standout
Lack of functional evidence for the involvement of sigma opiate receptors in the actions of the 3-PPP enantiomers on central dopaminergic systems: Discrepancies between and observations
1985 StandoutNobel
Works of R Hahn being referenced
Antagonism of leukotriene B4 receptors does not limit canine myocardial infarct size.
1990
Development of selective dopamine receptor agonists as novel cardiovascular drugs
1984
Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist.
1982
Absolute stereochemistry and dopaminergic activity of enantiomers of 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
1982
Antihypertensive activity of LY141865, a selective presynaptic dopamine receptor agonist.
1983
Dopaminergic activity of substituted 6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
1982
Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist.
1982
Depletion of cardiac norepinephrine in rats and mice by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
1984
4-(Aminoalkyl)-7-hydroxy-2(3H)-indolones, a novel class of potent presynaptic dopamine receptor agonists
1983
Further observations on the interaction of prostaglandin F2α with cholinergic mechanisms in canine salivary glands
1974
Resolution and absolute configuration of an ergoline-related dopamine agonist, trans-4,4a,5,6,7,8,8a,9-octahydro-5-propyl-1H(or 2H)-pyrazolo[3,4-g]quinoline
1983
Synthesis, renal vasodilator and dopamine‐sensitive adenylate cyclase activities ofO‐Methyl derivatives of 6‐chloro‐2,3,4,5‐tetr ahydro‐1‐(4‐hydroxyphenyl)‐1H‐3‐benzazepin‐7,8‐diol (SK&F 82526)
1986
Xanthine oxidase inhibition does not limit canine infarct size.
1991
Apomorphine-induced aggression in rats chronically treated with oral clonidine: modulation by central serotonergic mechanisms.
1982
Primate cardiovascular responses mediated by dopamine receptors: effects of N,N-di-n-propyldopamine and LY171555.
1984
Separation of potent central and renal dopamine agonist activity in substituted 6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepines
1980